QantX
  • Home
  • About us
  • For Investors
  • How we invest
  • Portfolio
  • Innovation Prize
  • News
  • Contact Us
Select Page
Xgenera

Xgenera

by Harry | Sep 10, 2024

Dynamic Therapeutics

Dynamic Therapeutics

by Harry | Jun 13, 2024

Lutra Health

Lutra Health

by Harry | Jun 10, 2024

Test text
iFAST Diagnostics

iFAST Diagnostics

by Harry | Jun 10, 2024

Neuronostics

Neuronostics

by Harry | Jun 10, 2024

« Older Entries

Latest Posts

  • Kelpi lands £4.3m funding to take seaweed packaging to market
  • Lutra Health raise £400,000 to transform eyecare pathways
  • QantX Launches New 2024 Fund to Champion Early-Stage, IP-Rich Startups in the South West
  • Celltris receives £800,000 investment to accelerate the development of lithium-ion cells
  • Portfolio company Neuronostics raise over £2M in oversubscribed seed round

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy